Skip to main content
. Author manuscript; available in PMC: 2011 Jan 15.
Published in final edited form as: Clin Cancer Res. 2010 Jan 12;16(2):727–735. doi: 10.1158/1078-0432.CCR-09-1303

Table 3. rhIL-7 pharmacokinetics.

Upper panel: mean serum concentrations for cohorts Lower panel: Pharmacokinetics parameters (mean values for a cohort). Results are shown after the first dose (d1) and after the last dose (d14) for each cohort.

Dose 10μg/Kg 30μg/Kg 60μg/Kg
rhIL-7 serum levels (pg/ml)
Time (hrs) d 1 d 14 d1 d 14 d 1 d 14
0 6 0 0 10 0 0
.5 51 35 506 372 534 929
1 93 48 837 399 908 1019
1.5 121 57 1335 616 1279 1324
2 148 66 1895 688 1246 1354
2.5 147 69 1766 426 1223 1344
4 354 83 1531 717 1176 1211
8 120 53 917 459 821 177
12 87 58 936 438 832 161
24 28 6 296 122 478 139
Pharmacokinetics parameters
Mean total
daily dose (μg)
686 686 2322 2322 4763 5280
Cmax (pg/ml) 354 83 1895 717 1846 1697
Tmax (h) 4.0 4.0 2.0 4.0 4.0 4.0
AUC total
(pg/ml*min)
168357 69697 1416470 591776 1812870 1483180
t ½ (h) 8.54 9.80 9.03 6.46 8.92 7.23
Clearance
(ml/min)
4077 9847 1639 3890 2627 3560